首页> 美国卫生研究院文献>Clinical Molecular Pathology >Use of immunohistochemical methods in the differential diagnosis between primary cerebellar haemangioblastoma and metastatic renal carcinoma.
【2h】

Use of immunohistochemical methods in the differential diagnosis between primary cerebellar haemangioblastoma and metastatic renal carcinoma.

机译:免疫组化方法在原发性小脑血管母细胞瘤和转移性肾癌之间的鉴别诊断中的应用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The potential role of immunohistochemistry in making the distinction between primary cerebellar haemangioblastoma and metastatic renal carcinoma was investigated by examining the reaction pattern of 10 cerebellar haemangioblastomas (seven women, three men, aged 20-40 years) and 10 primary renal carcinomas (six men, four women, aged 49-82 years) to a panel of epithelial, glial, and neuraleuroendocrine antisera. The tumour cell membranes of the renal carcinomas stained strongly with epithelial membrane antigen (EMA); membrane staining was totally absent in the haemangioblastomas. Strong neurone specific enolase (NSE) and S100 staining were also seen in haemangioblastomas but were more variable than EMA staining in renal carcinomas. It is concluded that a panel of antisera is required to distinguish between histologically similar areas in primary haemangioblastomas and metastatic renal carcinomas, and that while complementing conventional histological techniques, new problems of interpretation result which must be taken into account.
机译:通过检查10例小脑血管母细胞瘤(七名女性,三名男性,年龄20-40岁)和10例原发性肾癌(六名男性,六名男性,10名),研究了免疫组织化学在区分原发性小脑血管母细胞瘤和转移性肾癌中的潜在作用。四名年龄在49-82岁之间的女性)接受一系列上皮,神经胶质和神经/神经内分泌抗血清治疗。肾癌的肿瘤细胞膜被上皮膜抗原(EMA)强烈染色;血管母细胞瘤中完全没有膜染色。在血管母细胞瘤中也观察到强神经元特异性烯醇化酶(NSE)和S100染色,但在肾癌中比EMA染色变化更大。结论是,需要一组抗血清来区分原发性血管母细胞瘤和转移性肾癌的组织学相似区域,并且在补充常规组织学技术的同时,必须考虑新的解释问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号